JamesDavidsonFinkleaJr.MD

Pulmonology • Dallas, TX

Critical Care Medicine, Pleural Disease

Assistant Professor, Internal Medicine, University of Texas Southwestern Medical Center

Join to view full profile

Dr. Finklea is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Finklea's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-645-0599

Fax+1 214-645-3297

Education & Training

Emory University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Internal Medicine, 2006 - 2009
John Peter Smith Hospital (Tarrant County Hospital District)Residency, Family Medicine, 2004 - 2006
University of Texas Medical Branch School of MedicineClass of 2004

Certifications & Licensure

AR State Medical License 2023 - 2025
OK State Medical License 2022 - 2025
TX State Medical License 2008 - 2025
GA State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Development of metabolic syndrome in people with Cystic Fibrosis one year after exposure to elexacaftor-tezacaftor-ivacaftor.
Gregory A Ratti, Hannah Smith, Sasan Mirfakhraee, Joan Reisch, Leah Cohen
Journal of Cystic Fibrosis. 2024-10-16
Genomic epidemiology ofat an adult cystic fibrosis programme reveals low potential for healthcare-associated transmission.
Jane E Gross, James D Finklea, Silvia M Caceres, Katie R Poch, Nabeeh A Hasan
ERJ Open Research. 2024-07-01
6 citations
Sex differences in outcomes of people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor.
Angela Wang, MinJae Lee, Ashley Keller, Sarah Jian, Karen Lowe
Journal of Cystic Fibrosis. 2024-01-01

Journal Articles

Antimicrobial Susceptibility Study Ceftolozane/tazobactam Sensitivity Patterns in Pseudomonas Aeruginosa Isolates Recovered from Sputum of Cystic Fibrosis Patients
James D Finklea, Raksha Jain, Karen Lowe, Francesca Lee, ScienceDirect